Reduced brain norepinephrine metabolism in obese (ob/ob) mice is not normalized by tyrosine supplementation.
Five-week-old female lean and obese (ob/ob) mice were fed a 20% protein diet (1.1% tyrosine) or a 20% protein diet supplemented with tyrosine (4% tyrosine). On d 4 of supplementation, brain norepinephrine (NE) synthesis rate and brain efflux of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), a major metabolite of NE in mouse brain, were measured after administration of the monoamine oxidase inhibitor pargyline. Control obese mice had a lower rate of NE synthesis and a lower MHPG efflux than lean controls. Tyrosine supplementation elevated brain tyrosine concentration twofold, but had no effect on NE synthesis rate or MHPG efflux in either group. Likewise, tyrosine supplementation for up to 1 mo had no effect on food intake, oxygen consumption or body weight in obese mice and only a transient effect in lean mice, in which oxygen consumption was higher on d 2 and 3 and food intake was higher on d 3 and 4 compared with nonsupplemented lean mice. We conclude that tyrosine availability is not a limiting factor in the reduced brain noradrenergic activity of obese mice.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D004044:Dietary Proteins / Q000378:metabolism*; D005260:Female; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D010641:Phenotype; D013045:Species Specificity; D014443:Tyrosine / Q000097:blood / Q000494:pharmacology*
D004044:Dietary Proteins; D014443:Tyrosine; D008734:Methoxyhydroxyphenylglycol; D010293:Pargyline; D009638:Norepinephrine